HILLARY FLAHERTY: Open Payments
NPI 1194079590 · NORTH CHESTERFIELD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,568 in 157 payments from 50 companies in 2025. Trend: 2023 $2,197 · 2024 $2,604 · 2025 $3,568
Food & beverage: $3,599
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $437 |
| PFIZER INC. | 12 | $243 |
| Novartis Pharmaceuticals Corporation | 10 | $224 |
| Janssen Biotech, Inc. | 13 | $204 |
| Merck Sharp & Dohme LLC | 8 | $198 |
| Incyte Corporation | 7 | $143 |
| Gilead Sciences, Inc. | 5 | $131 |
| Amgen Inc. | 1 | $127 |
| ABBVIE INC. | 5 | $112 |
| Genentech USA, Inc. | 4 | $109 |
Products named: KEYTRUDA, TAGRISSO, Trodelvy, LYNPARZA, IMDELLTRA (AMG757), KISQALI, EPKINLY, Onivyde.
Industry payments across VA — which companies pay providers there.
